Back to Search
Start Over
Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours.
- Source :
-
Acta Oncologica . Jan2010, Vol. 49 Issue 1, p113-116. 4p. 2 Color Photographs. - Publication Year :
- 2010
-
Abstract
- A letter to the editor is presented about cutaneous side effects linked to treatment with mitogen-activated protein kinase inhibitor AZD6244 for patients with solid tumors.
- Subjects :
- *LETTERS to the editor
*PROTEIN kinases
Subjects
Details
- Language :
- English
- ISSN :
- 0284186X
- Volume :
- 49
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Acta Oncologica
- Publication Type :
- Academic Journal
- Accession number :
- 47696020
- Full Text :
- https://doi.org/10.3109/02841860903104152